Novamab
Shanghai, CN · 7 employees on LinkedIn · 1 known investors
Find your way into Novamab
138 people in our graph share verified history with the Novamab team — schools, employers, funds. One of them is your warm intro.
Brandon Alexanderunlockedknows Yakun Wan · together at The University of Texas at Austin (overlapped)
×2knows the team · via Chinese Academy Of Sciences
×6knows the team · via The University of Texas at Austin
×3knows the team · via Baylor College of Medicine
Nova (洛启生物 / Novamab) develops VHH-based (nanobody) therapeutics using its in-house discovery and molecular engineering platform, covering antibody library construction, high-throughput screening, affinity maturation, humanization, and developability assessment. The company targets applications such as local delivery, oral administration, and multispecific molecule design for drug development.
Founders & leadership
YW
Yakun WaninFounder & CEOYakun Wan founded Novamab, a Shanghai-based clinical-stage biopharmaceutical company, after working in nanobody drug research and development for over 17 years. The company develops VHH antibody candidates for respiratory and inflammatory diseases, including inhaled and oral formulations targeting asthma, COPD, and other immune-mediated conditions.
Investors · 1
In the news
Frequently asked questions
- What does Novamab do?
- Nova (洛启生物 / Novamab) develops VHH-based (nanobody) therapeutics using its in-house discovery and molecular engineering platform, covering antibody library construction, high-throughput screening, affinity maturation, humanization, and developability assessment. The company targets applications such as local delivery, oral administration, and multispecific molecule design for drug development.
- Who founded Novamab?
- Novamab was founded by Yakun Wan.
- Who are Novamab's investors?
- Novamab's investors include Qiming Venture Partners.
- Where is Novamab headquartered?
- Novamab is headquartered in Shanghai, CN.